biotech
Preliminary Trials s on PCV2 Swine Vaccine
Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture by ruth on February 17, 2007
Preliminary Trials s on PCV2 Swine Vaccine
Kansas State University researchers have developed what appears to be a promising vaccine against Porcine Circovirus Type 2 (PCV2), a prevalent disease in swine herds in the United States.
The trial results showed that in the finisher phase, the mortality rate for vaccinated pigs was 50 percent less than for unvaccinated pigs and that the growth rate for vaccinated pigs increased by about 10 percent. Results also showed that the average market weight for vaccinated pigs was about 20 pounds heavier for the same number of days to market when compared to unvaccinated pigs.

In a separate study of the vaccine in a commercial research finishing barn, mortality, growth rate and feed efficiency improvements were calculated to result in a benefit of $3.94 per pig.

Further studies are planned to verify the economical feasibility of the vaccine in infected herds with lower mortality rates.
Source: Kansas State University


Permalink: Preliminary Trials s on PCV2 Swine Vaccine
Tags: pigs  swine  agriculture  pig+industry  vaccine  Porcine+Circovirus  biotech  preliminary+trials 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/54012
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Preliminary Trials s on PCV2 Swine Vaccine:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 3 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!